The future’s bright for India’s top companies

Apart from the immediate challenges caused by the COVID-19 pandemic, India faces a weak health-care system, poor infrastructure, and is only very slowly implementing much-needed economic and political reforms.
Still, the country is home to a number of top global companies with bright futures. Here’s an… Read More

India’s growth potential remains powerful

High economic growth rates have helped swell India’s middle class over the past two decades. However, the country still comes in well below its main emerging market rival China in global competitiveness rankings.
Apart from the immediate challenges caused by the COVID-19 pandemic, the country… Read More

Commodities continue to shine

Stock markets, especially in the developed world, continued their rise in May. Commodity-producing nations, including Canada, lead the way. Notably, ETFs holding gold and oil producers were some of the big winners for the month.
On the other hand, decliners in the month included a.. Read More

Equities continued to rise in April

Equity markets in the developed world, especially North America, continued their upward climb in April while developing markets, especially India, struggled. REITs had another strong month, while selected commodities and miners also gained ground.
At the broad market level, the Vanguard Total World Stocks ETF… Read More

‘Bottom up’ works best

Here’s an Excerpt from a recent issue of Advice for Inner Circle Pro Members:
“Our Successful Investor approach employs bottom-up investing. That’s when you focus on what particular stocks are likely to do. You avoid the more complex task of figuring out the entire economy. That’s “top-down… Read More

Q: Hi, all. May I have TSI’s opinion on Stryker Corp.?

A: Stryker Corporation, $206.97, symbol SYK on New York (Shares outstanding: 373.1 million; Market cap: $76.8 billion;, is one of the world’s leading medical technology companies. The firm is based in Kalamazoo, Michigan.

Stryker’s investors benefit from its three business segments:

The Orthopaedics segment (37% of total revenue)… Read More

Q: Pat, can I get your opinion on Crescita Therapeutics Inc. (CTX)? Based on its recent quarterly financial performance, I am interested in getting your insights. Also, what do you think of its recent cannabis deal? Thank you.

A: Crescita Therapeutics, $0.96, symbol CTX on Toronto (Shares outstanding: 21.0 million; Market cap: $20.1 million;, is a dermatology company with manufacturing capabilities, a portfolio of non-prescription skincare products for the treatment and care of skin conditions and diseases, and prescription drug products for… Read More